Pharmacology, Toxicology and Pharmaceutical Science
Venous Thromboembolism
100%
Antivitamin K
92%
Cohort Study
82%
Atrial Fibrillation
53%
Bleeding
47%
Disease
43%
Heart Failure
33%
Arterial Thromboembolism
32%
Thromboembolism
32%
Multiple Myeloma
31%
Myelodysplastic Syndrome
31%
Direct Oral Anticoagulant
28%
Persistent Atrial Fibrillation
27%
Dabigatran
27%
Acenocoumarol
27%
Anticoagulant Agent
26%
Prothrombin Complex
25%
Vitamin D
24%
Protein S
24%
Ciclonicate
23%
Overall Survival
23%
Protein C
22%
Rivaroxaban
21%
Comorbidity
20%
Randomized Controlled Trial
19%
Antithrombin
18%
Ankylosing Spondylitis
18%
Thrombosis
16%
Prothrombin
15%
Recurrent Disease
15%
Blood Clotting Factor 5 Leiden
14%
Inflammation
14%
Digoxin
13%
Acute Myeloid Leukemia
13%
Subarachnoid Hemorrhage
13%
Peripheral Neuropathy
13%
Diffuse Large B Cell Lymphoma
13%
Alzheimer's Disease
13%
Infliximab
13%
Intervertebral Disk Hernia
13%
Nadroparin
13%
Chemotherapy
13%
Rituximab
12%
Statin (Protein)
12%
Apixaban
11%
Placebo
11%
Symptom
11%
Prospective Cohort Study
11%
Antiarrhythmic Agent
11%
Tumor Necrosis Factor
11%
Medicine and Dentistry
Venous Thromboembolism
79%
Vitamin K Antagonist
70%
Cohort Analysis
63%
Protein S
37%
Myelodysplastic Syndrome
36%
Disease
33%
Atrial Fibrillation
32%
Bleeding
30%
Protein C
28%
Phlebothrombosis
27%
Arterial Thromboembolism
25%
Hazard Ratio
25%
Diagnosis
24%
Antithrombin
24%
Overall Survival
23%
Asthma
23%
Multiple Myeloma
22%
Acute Myeloid Leukemia
22%
Heart Failure
20%
Vitamin D
20%
Systematic Review
19%
Quality of Life
18%
Ankylosing Spondylitis
18%
Artery Thrombosis
18%
Prothrombin Complex
18%
Ciclonicate
17%
Retrospective Study
17%
Factor V Leiden
16%
Left Anterior Descending Coronary Artery
16%
Thrombosis
16%
Recurrent Disease
16%
Stenosis
15%
Anticoagulation
15%
Thromboembolism
15%
Coronary Artery Disease
15%
Endothelial Function
15%
Antithrombotic
15%
Persistent Atrial Fibrillation
15%
Stenting
15%
Acetylcholine
15%
Prevalence
15%
Major Bleeding
14%
Gastric Bypass Surgery
14%
Cardioversion
14%
Surgeon
13%
Blood Clotting Factor 8
13%
Rapid Amplification of cDNA Ends
13%
Acenocoumarol
13%
Cross Sectional Study
13%
Fetus Death
13%
Keyphrases
Venous Thromboembolism
42%
Confidence Interval
22%
Arterial Thromboembolism
22%
Population-based Cohort Study
22%
Thrombophilic
21%
Atrial Fibrillation
20%
Risk Factors
18%
Multiple Myeloma Patients
18%
Dabigatran
16%
Rivaroxaban
15%
Vitamin D
14%
Non-vitamin K Antagonist Oral Anticoagulants
14%
Netherlands
14%
Dutch
13%
Minor Bleeding
13%
Direct Oral Anticoagulants
13%
Annual Incidence
11%
Family Cohort
11%
Vitamin K Antagonists
11%
Electrical Cardioversion
10%
Treatment Outcome
10%
Quality of Life
9%
Bariatric Surgery
9%
Peripheral Neuropathy
9%
Randomized pilot Trial
9%
Diffuse Large B-cell Lymphoma (DLBCL)
9%
Doxorubicin
9%
Dietary Protein
9%
Myelodysplastic Syndrome
9%
Postoperative Outcomes
9%
Amino Acid Composition
9%
Rhythm Control
9%
Rituximab
9%
Time in Therapeutic Range
9%
Oral Vitamin D
9%
Cyclophosphamide
9%
Inflammation of Unknown Origin
9%
Gastric Bypass Surgery
9%
Arthroplasty Surgery
9%
Nadroparin
9%
Comorbidity
9%
Bleeding
9%
Factor V Leiden
8%
Treatment Strategy
8%
Relative Risk
8%
Trough Level
7%
High Risk
7%
Deep Vein Thrombosis
7%
Pulmonary Embolism
7%
Absolute Risk
7%
